Sudeep Pharma, based in Vadodara, will open its initial public offering (IPO) on November 21. The company aims to raise ₹895 crore through a fresh issue of ₹95 crore and an offer-for-sale (OFS) of ₹800 crore. The price band is set at ₹563-593 per equity share, valuing the company near ₹6,700 crore at the top end. The issue will close on November 25. Investors can bid for a minimum lot of 25 shares, requiring a minimum investment of ₹14,825. Advertisement

The allotment is expected on November 26, with stock listing proposed for November 28. ICICI Securities Ltd and IIFL Capital Services are the book-running lead managers, and MUFG Intime India Pvt Ltd is the registrar.

The IPO includes reservations for Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail

See Full Page